# Intravenous Thrombolysis and NOAC

Study · id `cardio:ct-nct06749834` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06749834](<https://clinicaltrials.gov/study/NCT06749834>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06749834

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 280 participants.

## Technical summary

Registry record NCT06749834. Randomized; double masking; primary purpose treatment. Start 2025-01-27 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 280 participants (planned count; ClinicalTrials.gov record NCT06749834, source copy `cardio:ctgov-nct06749834-2025-02-24`, retrieved 2026-10-26)
- Started: 2025-01-27 (actual) (ClinicalTrials.gov record NCT06749834, source copy `cardio:ctgov-nct06749834-2025-02-24`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06749834, source copy `cardio:ctgov-nct06749834-2025-02-24`, retrieved 2026-10-26)
- Completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT06749834, source copy `cardio:ctgov-nct06749834-2025-02-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06749834, source copy `cardio:ctgov-nct06749834-2025-02-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06749834-2025-02-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intravenous Thrombolysis and NOAC
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Intravenous thrombolysis
- Lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine (`cardio:org-second-affiliated-hospital-zhejiang-university-school-of-bfd3ac`)

## Provenance

Content hash: 5939001f188211544b284b0d56ebc3063ca1853e41eabdcc42b2d64d87400a5d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
